Navigation Links
GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009.
Date:11/24/2008

WHEAT RIDGE, Colo., Nov. 24 /PRNewswire-FirstCall/ -- GeneThera, Inc. (Pink Sheets: GTHR.PK), announces it will soon begin offering its Real Time PCR test for Johne's disease through its Wheat Ridge, Colo. laboratory.

GeneThera is set to begin offering its Johne's disease testing service as soon as January of 2009. According to GeneThera Chairman, Dr. Tony Milici MD, Ph.D., "We expect to be offering our real time PCR test for Johne's disease, called HerdGuard(TM) by the first of the year on a commercial level. We are already receiving inquiries from several companies as to the availability of the service."

The company states that its PCR test is much more accurate and timely than what is commonly available today. There are other PCR tests available, but what makes GeneThera's service different is exactly that... service. According to the company; "the other PCR tests that are available require the purchase of a test kit from one supplier, and then forwarding the collected samples to a completely different company for analyzing. In other words, the customer has to collect the samples (usually fecal) and send the collected samples to a separate approved laboratory for actual testing. This means the customer is responsible for finding the lab, negotiating the cost of the testing, shipping, and retrieving the results. GeneThera's service is all inclusive. Using their trademarked Field Collection System (FCS(TM)), the client collects the sample (blood, milk, fecal, or colostrum), and then returns them to GeneThera's lab for testing and reporting of the results. The results will be available to customers via a secured web page on GeneThera's website. Everything is included in the price from GeneThera. Pricing is expected to be between $25 and $32 per test, and results are typically available within 24-48 hours of receipt of the samples."

According to a recent study, the infected rate of dairy ca
'/>"/>

SOURCE GeneThera, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Medarex Announces Initiation of Phase 1b Clinical Development Program with MDX-1106 for the Treatment of Cancer
2. Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream
3. Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351
4. Portola Announces Data Showing Its Anti-Platelet Drug Inhibits Platelets in Clopidogrel (Plavix(R)) Non-Responders
5. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
6. Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease
7. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
8. Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring
9. Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test
10. VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
11. Celladon Announces Presentation of Clinical Data From First-in-Human MYDICAR(R) Trial for Advanced Heart Failure at American Heart Association Scientific Sessions

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...er option to prevent illnesses caused by subtypes ..., Nov. 27 The U.S. Food...r people ages 18 years and older to prevent diseas..., (Logo: http://www.newscom.com/cgi-bin/prnh/20...vartis Vaccines and Diagnostics in Siena, Italy, w...
(Date:11/25/2009)...RK, Calif., Nov. 25 Praxis Electro...in the American Academy of Family Physicians, (AAF...Satisfaction Survey for improving medical quality,...ritical for new ARRA Stimulus legislation. Praxis ...had a positive effect in determining their salary....
(Date:11/25/2009)...ELPHIA, Nov. 25 ERT (Nas...McKelvey, the Company,s President and CEO, and Kei... and CFO, are scheduled to present at the 21st Ann...M EST on December 1, 2009 in New York City, New Yo...tation by visiting the Company,s corporate website...
Breaking Medicine Technology:FDA Approves Agriflu Seasonal Influenza Vaccine 2Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2TOPAZ Technologies and Tecniplast USA Launch RFID Mobile Census 6015 1TOPAZ Technologies and Tecniplast USA Launch RFID Mobile Census 6015 2TOPAZ Technologies and Tecniplast USA Launch RFID Mobile Census 6015 3Amgen Announces Overall Survival Results for Vectibix 28R 29 in First Line Metastatic Colorectal Cancer 6010 1Amgen Announces Overall Survival Results for Vectibix 28R 29 in First Line Metastatic Colorectal Cancer 6010 2Amgen Announces Overall Survival Results for Vectibix 28R 29 in First Line Metastatic Colorectal Cancer 6010 3Amgen Announces Overall Survival Results for Vectibix 28R 29 in First Line Metastatic Colorectal Cancer 6010 4Amgen Announces Overall Survival Results for Vectibix 28R 29 in First Line Metastatic Colorectal Cancer 6010 5Amgen Announces Overall Survival Results for Vectibix 28R 29 in First Line Metastatic Colorectal Cancer 6010 6Amgen Announces Overall Survival Results for Vectibix 28R 29 in First Line Metastatic Colorectal Cancer 6010 7Amgen Announces Overall Survival Results for Vectibix 28R 29 in First Line Metastatic Colorectal Cancer 6010 8Babies language learning starts from the womb 60760 1Babies language learning starts from the womb 60760 2
... 7 GeoVax Labs, Inc. (OTC,Bulletin Board: GOVX), ...l,company specializing in the prevention and treat...rational update on the company,s progress,towards ... testing and,plans to proceed into therapeutic hum...uman trials evaluating GeoVax AIDS vaccines have p...
... N.Y., July 7 The Leukemia & Lymphoma,Society has...D., M.M.Sc.,of the James P. Wilmot Cancer Center a...ennium Pharmaceuticals, The Takeda Oncology Compan...ears of the five-year program., The Scholar in Cl...ort,Dr. Friedberg,s work on a new targeted treatme...
Other Medicine Technology:GeoVax Reports Progress on Its AIDS Vaccine Technology 2GeoVax Reports Progress on Its AIDS Vaccine Technology 3GeoVax Reports Progress on Its AIDS Vaccine Technology 4GeoVax Reports Progress on Its AIDS Vaccine Technology 5University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society 2
(Date:11/28/2009)... Study finds gene variation believed to affect cir...(HealthDay News) -- New research suggests that an ...e a factor in the development of bipolar disorder ...amination of the genetic makeup of 152 children wi...ible to major mood swings, and 140 children withou...
(Date:11/27/2009)..., Biotech firm Replikins ...of the H1N1 virus genomic data. It shows that the...of 3.7 (s.d. 4.5) during the virus,s current outbr...levels this week of 2.0 (s.d. 0.1). The H1N1 infec... Boston (PRWEB) November 27, 200...
(Date:11/27/2009)..., , NEUILLY-SUR-SEINE, France, Nov. 27 ...American professional cycling team dedicated to et...of cycling champions, announced today that it will...of Transitions Optical as a new sponsor of the tea...facturer of adaptive eyewear, offering the most ad...
(Date:11/27/2009)... Soaring rates to bring unprecedented medical, eco..., Nov. 27 (HealthDay News) -- The number of people... double over the next 25 years, a new study predic...ut 44.1 million people with the disease, up from 2...t of treating people with diabetes will triple, th...
(Date:11/27/2009)..., Specialist manufacturer... products are saving millions of dollars by bringi...gn process. Increasing numbers of pro-active medic...experts at the concept stage of their projects, en...isting design processes or potentially outdated te...
Breaking Medicine News(10 mins):Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4
...search Funding to Prevent Setbacks in the Fight Ag...rch 16 With thousands of Americans losing health ...warns lawmakers that recent progress in reducing t...n, American Heart Association leadership outlined ...
...s safe and effective against heart attack in men, ...thDay News) -- Amid the continuing debate over who...ease, and at what dose, U.S. experts have revised ... dosage has long been discussed because aspirin ca...
... us the nation is getting fatter, and that obesity...story, according to one University of Houston soci...been a shift in body weight over the years, assist...an says. And the use of the Body Mass Index, which...
...ISCO, Calif., March 16 Poniard Pharmaceuticals, I... focused on oncology, today announced that its aud...d December 31, 2008, included in the Company,s Ann...This announcement is required by Nasdaq Marketplac...
...ose monitoring offers some men better quality of l...-- Refusing immediate treatment can be safe for me... monitored, new research finds. , The multi-cente...n a challenging question that faces patients and u...
...er of Health Systems Operating Retail-Based Care ,...onvenient care clinics across the country steadily...tems are exploring this relatively new health care...ally for non-profit health systems. , , The goal ...
Other Medicine News:Health News:American Heart Association Urges Congress to Accelerate Efforts to Enact Comprehensive Health Care Reform 2Health News:American Heart Association Urges Congress to Accelerate Efforts to Enact Comprehensive Health Care Reform 3Health News:American Heart Association Urges Congress to Accelerate Efforts to Enact Comprehensive Health Care Reform 4Health News:Experts Revise Guidelines on Daily Aspirin for Heart 2Health News:Experts Revise Guidelines on Daily Aspirin for Heart 3Health News:UH sociologist has different perspective on obesity 'epidemic' 2Health News:UH sociologist has different perspective on obesity 'epidemic' 3Health News:Poniard Pharmaceuticals Receives Going Concern Qualification 2Health News:'Watchful Waiting' Safe With Low-Risk Prostate Cancers 2Health News:Convenient Care Association Forms Round-Table for Health Systems Operating Convenient Care Clinics 2
Low Contrast Flip Chart with Lea Symbols
HOTV Distance Acuity Chart BCDI
Symbol 10' Test Chart BCS10
Binkhorst Hooked Cannula
Medicine Products: